Color Code
Brown

Griffithsin-based Rectal Microbicides Study

811
HIV
Griffithsin-based Rectal Microbicides Study
Georgia, Kentucky, Pennsylvania, USA
United States of America
To evaluate the effectiveness of the Griffithsin gel treatment.
University of Louisville; University of Louisville Research Foundation (National Institutes of Health)
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Healthy Swimming in the United States

252
swimming
Healthy Swimming in the United States
United States of America
To conduct research and raise awareness about preventing recreational water illness associated with the use of treated public water venues such as pools, hot tubs and water parks.
National Swimming Pool Foundation; ESSRX; Lupin Pharmaceuticals; Previous Partners: American Chemistry Council; Chem-Aquascience, Inc.; Lonza Group, Ltd (Arch Chemicals, Inc.); NSPF for CMAHC; Slack, Inc.
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Genomic Epidemiology of Neisseria Gonorrhoeae

778
CDC scientist
Genomic Epidemiology of Neisseria Gonorrhoeae
United States of America
To study demographic data and Neisseria gonorrhoeae isolates collected as part of the Gonococcal Isolate Surveillance Project and to look at within-host diversity in an ongoing study of extra- genital gonococcal infection.
Brigham and Women's Hospital (Partners HealthCare System, Inc.)
CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

Crimean-Congo Hemorrhagic Fever Study

794
Map
Crimean-Congo Hemorrhagic Fever Study
United States of America
To research the nairovirus, Crimean-Congo hemorrhagic fever, a tick-borne viral disease, especially common in East and West Africa. With mortality rates as high as 80 percent and with no FDA approved vaccines or therapeutics, Crimean-Congo hemorrhagic fever is considered a dangerous pathogen and a serious bioterrorism threat. The project will expand the knowledge of the ovarian tumor protease domain of the nairovirus to inform control measures and vaccine development.
University of Georgia (National Institutes of Health)
CDC's National Center for Emerging and Zoonotic Infectious Diseases

The Sally Schieffelin Potter Endowment for Healthcare-Associated Infections

Safe HeathcareEvery day, about one in every 20 hospitalized patients has an infection caused by receiving medical care. Healthcare-associated infections are caused by a wide variety of bacteria, fungi and viruses, and one in every five healthcare-associated infections are caused by germs that show concerning multidrug resistance. Although many of these infections are preventable, tens of thousands of people die each year as a result, and countless others are left to deal with devastating emotional, financial and medical consequences. These infections cost the U.S. healthcare system up to $45 billion dollars annually.

The Centers for Disease Control and Prevention (CDC) is working toward the elimination of healthcare-associated infections in all medical care settings. CDC is passionate about improving the safety of our nation’s healthcare system, but they cannot do it alone. The CDC Foundation and CDC need the help of businesses globally to bring innovations to patient safety that ensures our healthcare system is fail-proof. There are five key areas where CDC is helping healthcare facilities, doctors and nurses provide safer care for patients, providing better options for healthcare purchasers and saving healthcare dollars. These include:
 

  • Tracking infections in more than 12,000 healthcare facilities to know where the problems are and better target prevention efforts through CDC’s National Healthcare Safety Network;
  • Publishing evidenced-based guidelines that can prevent infections in the first place;
  • Leading novel research to find new strategies to protect patients and help innovators bring new products forward that improve healthcare;
  • Stopping outbreaks and sounding the alarm on emerging threats; and
  • Operating a world-class laboratory that can track drug-resistant threats and evaluate the role of the healthcare environment in infection transmission.

CDCPreventing infections saves lives. There are a variety of innovative business strategies that could help boost CDC’s infection prevention challenges and address emerging threats.

The Sally Schieffelin Potter Endowment for Healthcare-Associated Infections was created to provide financial support to the CDC’s Division of Healthcare Quality Promotion who is working to protect patients wherever they receive their medical care.

In 2013, the Sally Schieffelin Potter Endowment for Healthcare-Associated Infections was used to provide educational materials for healthcare workers and dialysis patients in the nearly 6,000 dialysis facilities in the United States. Each year, about 37,000 bloodstream infections affect kidney dialysis patients with central lines. Following CDC protocols could cut bloodstream infections among dialysis patients in half.

60
HAI
The Sally Schieffelin Potter Endowment for Healthc
United States of America
To provide support to CDC, working toward the elimination of healthcare-associated infections in all medical care settings.
Multiple individuals and organizations; Previous Partner: The Sally Schieffein Potter Endowment
CDC's National Center for Emerging and Zoonotic Infectious Diseases

Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study

768
world
Sustainable Health Center Implementation PrEP Pilo
Illinois, Mississippi, Pennsylvania and Washington D.C., USA
United States of America
To learn lessons about how best to incorporate the delivery of daily oral pre-exposure prophylaxis (PrEP) into the services provided by health centers serving sexually active adults at high risk of acquiring HIV infection. The pilot study will initiate data collection at federally-qualified health centers (FQHCs) or look-alikes in four U.S. cities.
Gilead Sciences, Inc.
CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Central Care Community Health Center; Strawberry Mansion Health Center; Access Community Health Network – Grand Boulevard Clinic; Newark Community Health Centers, Inc.; University of Colorado

Multistate Fungal Meningitis Outbreak Management

742
environmental health
Multistate Fungal Meningitis Outbreak Management
United States of America
To respond to an unprecedented outbreak of central nervous system, joint and osseous mold infections that have been observed, beginning in August of 2012, among hundreds of patients who received contaminated methylprednisolone injections. This project will collect long-term follow-up data on diagnosis and appropriate treatment of fungal meningitis and other fungal infections associated with this outbreak in order to fully understand and track the burden of these infections.
Springer Science+Business Media LLC
CDC’s National Center for Emerging and Infectious Zoonotic Diseases

Rift Valley Fever Virus Vaccination Development

707
Rift Valley
Rift Valley Fever Virus Vaccination Development
United States of America
To assist in the development of novel vaccines and comprehensive strategies for the prevention of Rift Valley Fever virus in both livestock and humans using recombinant proteins and 96-well ELISA or Luminex platforms to detect anti-NP, anti-NSs or anti-NSm antibodies.
Texas A&M University
CDC’s National Center for Emerging and Zoonotic Infectious Diseases

Global Burden of Foodborne Norovirus

684
food
Global Burden of Foodborne Norovirus
United States of America
To estimate incidence rates of gastroenteritis due to norovirus by age and country/WHO region, taking; to describe and quantify the available data on health effects resulting from these infections; to estimate the proportion of norovirus that is foodborne; and to provide a critical appraisal of data gaps.
World Health Organization
CDC's National Center for Immunization and Respiratory Diseases

Point-of-Care Diagnostics for Norovirus

674
Norovirus
Point-of-Care Diagnostics for Norovirus
United States of America
To help CDC collaborate in a larger norovirus study by developing glycan-based assays to evaluate a panel of different synthetic glycans as well as norovirus stool strains.
Georgia State University (National Institutes of Health)
CDC's National Center for Immunization and Respiratory Diseases
Subscribe to Infectious Disease